Product Program year 2023 Source: CMS Open Payments

Jzp-150

Open in the dashboard

General payments

$192,324

14 payments

Research payments

$0

0 payments

Through program year 2023, $192,324 in general payments and $0 in research payments were reported against Jzp-150.

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2023 General $192,324 14

Breakdown

Who paid General payments · program year 2023
  1. Jazz Pharmaceuticals Inc. $192,324 14 payments
Top recipients General payments · program year 2023
  1. Revati Shreeniwas Pulmonary Disease · Stanford, CA $180,200 94% · 3 payments
  2. Wayne Hellstrom Urology · New Orleans, LA $7,000 4% · 5 payments
  3. Anthony Scialli Gynecology · Washington, DC $2,700 1% · 3 payments
  4. Katherine Moretz Neurology with Special Qualifications in Child Neurology · Savannah, GA $808 <1% · 1 payment
  5. Sookyong Koh Neurology with Special Qualifications in Child Neurology · Chicago, IL $808 <1% · 1 payment

The top 5 of 6 recipients; each share is of general payments naming this product in 2023.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2023
  1. Pulmonary Disease Internal Medicine $180,200 94% · 1 practitioner
  2. Urology $7,000 4% · 1 practitioner
  3. Gynecology Obstetrics & Gynecology $2,700 1% · 1 practitioner
  4. Neurology with Special Qualifications in Child Neurology Psychiatry & Neurology $2,424 1% · 3 practitioners

Each share is of general payments naming this product to practitioners with a specialty in 2023. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2023
  1. California $180,200 94% · 1 recipient
  2. Louisiana $7,000 4% · 1 recipient
  3. District of Columbia $2,700 1% · 1 recipient
  4. Georgia $808 <1% · 1 recipient
  5. Illinois $808 <1% · 1 recipient

The top 5 of 6 states; each share is of general payments naming this product in 2023 where a state was reported.

The top 25 states, free in the app

14 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2023

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record